Literature DB >> 9876035

Iatrogenic vascular trauma.

M R Nehler1, L M Taylor, J M Porter.   

Abstract

With the increasing performance of percutaneous transluminal angioplasty and insertion of an increasing number of intravascular devices, the size of arterial punctures has been increasing. A consistent minority of these procedures will result in vascular injuries requiring treatment. At the same time, the regionalized nature of trauma care in the United States has resulted in a large number of vascular surgeons who are exposed to vascular trauma only when iatrogenic. The most common injuries observed are caused by percutaneous vascular instrumentation and include hemorrhage and pseudoaneurysm that may compress adjacent structures, fistula, acute occlusion, and embolization. Injuries unique to balloon angioplasty/stenting include arterial rupture and dissection. Indwelling intravascular devices are another common source of iatrogenic vascular injury ranging from arterial rupture to thrombosis and embolization. Much less common injuries are observed in orthopedic and abdominal/laparoscopic operations but show reproducible causes/patterns. Finally, pediatric iatrogenic vascular trauma is relatively common because of the small size of the vasculature, but the natural history and management is markedly different from that in adults.

Entities:  

Mesh:

Year:  1998        PMID: 9876035

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  14 in total

Review 1.  Interventional radiology for paediatric trauma.

Authors:  Manrita K Sidhu; Mark J Hogan; Dennis W W Shaw; Thomas Burdick
Journal:  Pediatr Radiol       Date:  2008-12-17

2.  Peripheral Arterial Injuries: an Indian Experience.

Authors:  Sunil S Joshi
Journal:  Indian J Surg       Date:  2015-09-10       Impact factor: 0.656

3.  Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology.

Authors:  Manraj K S Heran; Francis Marshalleck; Michael Temple; Clement J Grassi; Bairbre Connolly; Richard B Towbin; Kevin M Baskin; Josee Dubois; Mark J Hogan; Sanjoy Kundu; Donald L Miller; Derek J Roebuck; Steven C Rose; David Sacks; Manrita Sidhu; Michael J Wallace; Darryl A Zuckerman; John F Cardella
Journal:  Pediatr Radiol       Date:  2010-02

4.  Iatrogenic and non-iatrogenic vascular trauma in a district general hospital: a 21-year review.

Authors:  Henry D I De'Ath; Robert B Galland
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

5.  Percutaneous ultrasound-guided thrombin injection is effective even in infants with external iliac artery pseudoaneurysms.

Authors:  Min-Jung Cho; Ung-Bae Jeon; Ki-Seok Choo; Hyoung-Doo Lee
Journal:  Korean J Pediatr       Date:  2014-04-30

6.  Access-site complications after rescue percutaneous coronary intervention during thrombolysis for acute myocardial infarction.

Authors:  A Germing; M Lindstaedt; S Ulrich; W Bojara; T Lawo; A Mügge; P Grewe
Journal:  Z Kardiol       Date:  2005-01

7.  Large femoral aneurysm as a late complication after vessel closure device application.

Authors:  Alfried Germing; Peter Grewe; Andreas Mügge; Michael Lindstaedt
Journal:  Clin Res Cardiol       Date:  2006-04-03       Impact factor: 5.460

8.  Outcome of iatrogenic injuries to the abdominal and pelvic veins.

Authors:  Tommaso Mandolfino; Aldo Canciglia; Filippo Taranto; Mario D'Alfonso; Agata Tonante; Marcello Mamo; Giovanni Sturniolo
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

9.  Iatrogenic major venous injuries incurred during cancer surgery.

Authors:  Gursel Levent Oktar
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

10.  Intraoperative injuries during liver resection: analysis of 1,005 procedures.

Authors:  Michal Grat; Karolina Grzegorczyk; Zbigniew Lewandowski; Damian Sujecki; Dawid Szwedowski; Adam Boltuc; Piotr Smoter; Oskar Kornasiewicz; Marek Krawczyk
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.